NCT06932107View on ClinicalTrials.gov

Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting

PHASE3CompletedINTERVENTIONAL
Enrollment

518

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

May 28, 2024

Study Completion Date

June 5, 2024

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

Aprepitant Injection

Before anesthesia induction, 4.4ml(32mg） was given by a single intravenous injection, which was completed within 30 seconds

DRUG

Aprepitant Injection Placebo

Before anesthesia induction, 4.4ml was given by a single intravenous injection, which was completed within 30 seconds

Trial Locations (1)

Unknown

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan

All Listed Sponsors
lead

Qilu Pharmaceutical (Hainan) Co., Ltd.

INDUSTRY

NCT06932107 - Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting | Biotech Hunter | Biotech Hunter